Expression of PD-L1/IDO1 and Tumor Infiltrating Lymphocytes Status in Renal Cell Carcinoma with Sarcomatoid Changes and Rhabdoid Features

被引：0
|
作者：
Kiyozawa, Daisuke
Takamatsu, Dai [1 ]
Kohashi, Kenichi [1 ]
Oda, Yoshinao [1 ]
机构：
[1] Kyushu Univ, Fukuoka, Japan
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
944
引用
收藏
页码：914 / 914
页数：1
相关论文
共 50 条
  • [1] Expression of PD-L1/IDO1 and Tumor Infiltrating Lymphocytes Status in Renal Cell Carcinoma with Sarcomatoid Changes and Rhabdoid Features
    Kiyozawa, Daisuke
    Takamatsu, Dai
    Kohashi, Kenichi
    Oda, Yoshinao
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 914 - 914
  • [2] PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients
    Toda, Yu
    Kohashi, Kenichi
    Yamada, Yuichi
    Ishihara, Shin
    Ito, Yoshihiro
    Yamamoto, Hidetaka
    Oda, Yoshinao
    CANCER SCIENCE, 2021, 112 : 514 - 514
  • [3] PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions
    Toda, Yu
    Kohashi, Kenichi
    Yamada, Yuichi
    Yoshimoto, Masato
    Ishihara, Shin
    Ito, Yoshihiro
    Iwasaki, Takeshi
    Yamamoto, Hidetaka
    Matsumoto, Yoshihiro
    Nakashima, Yasuharu
    Mawatari, Masaaki
    Oda, Yoshinao
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (10) : 2607 - 2620
  • [4] PD-L1 and IDO1 expression and tumor-infiltrating lymphocytes in osteosarcoma patients: comparative study of primary and metastatic lesions
    Yu Toda
    Kenichi Kohashi
    Yuichi Yamada
    Masato Yoshimoto
    Shin Ishihara
    Yoshihiro Ito
    Takeshi Iwasaki
    Hidetaka Yamamoto
    Yoshihiro Matsumoto
    Yasuharu Nakashima
    Masaaki Mawatari
    Yoshinao Oda
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2607 - 2620
  • [5] PD-1 and PD-L1 Expression in Renal Cell Carcinoma with Sarcomatoid Differentiation
    Joseph, Richard W.
    Millis, Sherri Z.
    Carballido, Estrella M.
    Bryant, David
    Gatalica, Zoran
    Reddy, Sandeep
    Bryce, Alan H.
    Vogelzang, Nicholas J.
    Stanton, Melissa L.
    Castle, Erik P.
    Ho, Thai H.
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (12) : 1303 - 1307
  • [6] The association between PD-1 / PD-L1 expression and clinicopathological features in sarcomatoid renal cell carcinoma
    Zhao, Yuan
    Shi, Zhongyue
    Xie, Yan
    Li, Ning
    Chen, Hong
    Jin, Mulan
    ASIAN JOURNAL OF SURGERY, 2024, 47 (01) : 163 - 168
  • [7] Programmed death ligand 1/indoleamine 2,3-dioxygenase 1 expression and tumor-infiltrating lymphocyte status in renal cell carcinoma with sarcomatoid changes and rhabdoid features
    Kiyozawa, Daisuke
    Takamatsu, Dai
    Kohashi, Kenichi
    Kinoshita, Fumio
    Ishihara, Shin
    Toda, Yu
    Eto, Masatoshi
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2020, 101 : 31 - 39
  • [8] PD-L1 Expression in Tumor-Infiltrating Lymphocytes of Invasive Breast Carcinoma
    Hoda, Raza
    Brogi, Edi
    Grabenstetter, Anne
    Patil, Sujata
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge
    Traina, Tiffany
    Robson, Mark
    Norton, Larry
    Wen, Hannah
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 177 - 179
  • [9] PD-L1 Expression in Tumor-Infiltrating Lymphocytes of Invasive Breast Carcinoma
    Hoda, Raza
    Brogi, Edi
    Grabenstetter, Anne
    Patil, Sujata
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge
    Traina, Tiffany
    Robson, Mark
    Norton, Larry
    Wen, Hannah
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 177 - 179
  • [10] Expression of PD-1 and PD-L1 in patients with renal cell carcinoma with sarcomatoid dedifferentiation (sRCC).
    Kawakami, Fumi
    Sircar, Kanishka
    Rodriguez-Canales, Jaime
    Tamboli, Pheroze
    Tannir, Nizar M.
    Jonasch, Eric
    Wistuba, Ignacio Ivan
    Wood, Christopher G.
    Karam, Jose A.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345